Learn About an FDA-Approved Indication for OFEV® (nintedanib) capsules
Speakers: Rajeev Saggar, MDGuillermo J. Valenzuela, MD, F.A.C.R.
Duration: 35 minutes
Presented on: December 19, 2019
*This session is not eligible for AMA PRA Category 1 CreditsTM
Rajeev Saggar, MD
Rajeev Saggar, MDDr. Rajeev Saggar is a pulmonologist in Phoenix, Arizona and is affiliated with Banner University Medical Center Phoenix and Tucson. He received his medical degree from University of California Irvine School of Medicine and has been in practice since 2008. He currently serves as Associate Professor of Medicine at the University of Arizona, Phoenix as well as the Director of Pulmonary Fibrosis and Pulmonary Hypertension Programs.
Guillermo J. Valenzuela, MD, F.A.C.R.
Guillermo J. Valenzuela, MD, F.A.C.R.Guillermo Valenzuela, MD, is a Rheumatologist, key opinion leader, President of the Florida Society of Rheumatology, and Director of Integral Rheumatology & Immunology Specialists, and IRIS Research and Development. Dr. Valenzuela’s clinical practice is based in South Florida at Integral Rheumatology & Immunology Specialists, and his research institute is based at IRIS Research and Development. He earned his Medical Doctor degree, with honors, at the University of Buenos Aires in Argentina, and completed his Internal Medicine training at New York Medical College. He then completed his Post-Doctoral Fellowship in Clinical Immunology, and Fellowship in Rheumatology & Clinical Immunology at Cornell University Medical College in New York.